Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

G. Antonelli,E. Simeoni,F. Bagnato,C. Pozzilli,O. Turriziani,R. Tesoro,P. Marco,C. Gasperini,C. Fieschi,F. Dianzani
DOI: https://doi.org/10.1016/S0022-510X(99)00185-9
1999-10-15
Journal of Neurological Sciences
Abstract:
What problem does this paper attempt to address?